A Study to Evaluate the Safety, Tolerability, and Drug Levels of Danicamtiv in Healthy Japanese and Caucasian Participants
Palo Alto (17 mi)Age: 18 - 65
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: Phase 1
Waitlist Available
Sponsor: Bristol-Myers Squibb
No Placebo Group
Trial Summary
What is the purpose of this trial?The purpose of this study is to assess the safety, tolerability, and single-dose pharmacokinetics of danicamtiv in healthy Japanese and Caucasian participants.
Eligibility Criteria
Treatment Details
4Treatment groups
Experimental Treatment
Group I: Japanese Cohort - Dose 3Experimental Treatment2 Interventions
Group II: Japanese Cohort - Dose 2Experimental Treatment2 Interventions
Group III: Japanese Cohort - Dose 1Experimental Treatment2 Interventions
Group IV: Caucasian Cohort - Dose 3Experimental Treatment2 Interventions
Find a clinic near you
Research locations nearbySelect from list below to view details:
Anaheim Clinical TrialsAnaheim, CA
Loading ...
Who is running the clinical trial?
Bristol-Myers SquibbLead Sponsor